Pramlintide/metreleptin: Phase II halted

Amylin and partner Takeda suspended a double-blind, placebo-controlled, U.S. Phase II trial of pramlintide/metreleptin to treat obesity after 2 patients in a previously completed study developed "antibody-related" responses to metreleptin. According to

Read the full 326 word article

How to gain access

Continue reading with a
two-week free trial.